CompletedNot Applicable

Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia

Germany63 participantsStarted 2017-09-01

Plain-language summary

Cervical intraepithelial neoplasia will be treated with physical low temperature plasma in the plasma cohort compared to watchful waiting in the control cohort. Primary endpoint after 3-6 months: Pathological remission. Secondary endpoint: HPV remission.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for CAP: * Histologically confirmed CIN I / II * Reliable assessment of the radius of the portio and marginal borders of the lesions * Written consent for treatment with low temperature plasma after reconnaissance Inclusion Criteria for Control-Group: * Histologically confirmed CIN I / II * Reliable assessment of the radius of the portio and marginal borders of the lesions * Patients who want a waiting procedure and a control examination after 3-6 months Exclusion Criteria: * Histologically confirmed CIN III * Not fully visible transformation zone * An indication of invasive disease * Expected lack of compliance of the patient or incapacity of the patient to understand the meaning and purpose of the clinical trial * Severe cardio-vascular disease * Lack of patient consent

What they're measuring

Pathological remission of cervical intraepithelial neoplasia

Timeframe: 3-6 months

Trial details

NCT IDNCT03218436

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-31

View on ClinicalTrials.gov More Cervical Intraepithelial Neoplasia trials